Submitted:
05 August 2025
Posted:
06 August 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Nutritional Data
2.3. Semen Quality Assessment
2.4. Blood Analysis and Anthropometric Measurements
2.5. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| WHO | World Health Organization |
| BMI | Body Mass Index |
| IQR | interquartile range |
| LDL | Low-Density Lipoprotein |
| VLDL | Very Low-Density Lipoprotein |
| HDL | High-Density Lipoprotein |
| E | Energy |
| FE | Fat Energy |
| TPI | Total Polyphenols Intake |
| PA | Phenolic Acids |
| OPP | Other Polyphenols |
References
- World Health Organization Infertility Prevalence Estimates; 2021; ISBN 9789240068315.
- Caroppo, E.; Colpi, G.M. Male Infertility: A Review of Key Papers Appearing in the Reproductive Medicine and Andrology Section of the Journal of Clinical Medicine. J. Clin. Med. 2023, 12, 12–14. [CrossRef]
- Balawender, K.; Orkisz, S. The Impact of Selected Modifiable Lifestyle Factors on Male Fertility in the Modern World. Cent. Eur. J. Urol. 2020, 73, 1–6. [CrossRef]
- Cao, L.L.; Chang, J.J.; Wang, S.J.; Li, Y.H.; Yuan, M.Y.; Wang, G.F.; Su, P.Y. The Effect of Healthy Dietary Patterns on Male Semen Quality: A Systematic Review and Meta-Analysis. Asian J. Androl. 2022, 24, 549–557. [CrossRef]
- Karayiannis, D.; Kontogianni, M.D.; Mendorou, C.; Douka, L.; Mastrominas, M.; Yiannakouris, N. Association between Adherence to the Mediterranean Diet and Semen Quality Parameters in Male Partners of Couples Attempting Fertility. Hum. Reprod. 2017, 32, 215–222. [CrossRef]
- Petre, G.C.; Francini-pesenti, F.; Nisio, A. Di; Toni, L. De; Grande, G.; Mingardi, A.; Cusmano, A.; Spinella, P.; Ferlin, A.; Garolla, A. Observational Cross-Sectional Study on Mediterranean Diet and Sperm Parameters. 2023.
- Zhang, L.; Han, Z.; Granato, D. Polyphenols in Foods: Classification, Methods of Identification, and Nutritional Aspects in Human Health; 1st ed.; Elsevier Inc., 2021; Vol. 98; ISBN 9780128225066.
- Kiani, A.K.; Medori, M.C.; Bonetti, G.; Aquilanti, B.; Velluti, V.; Matera, G.; Iaconelli, A.; Stuppia, L.; Connelly, S.T.; Herbst, K.L.; et al. Modern Vision of the Mediterranean Diet. J. Prev. Med. Hyg. 2022, 63, E36–E43. [CrossRef]
- Kiyimba, T.; Yiga, P.; Bamuwamye, M.; Ogwok, P.; Van der Schueren, B.; Matthys, C. Efficacy of Dietary Polyphenols from Whole Foods and Purified Food Polyphenol Extracts in Optimizing Cardiometabolic Health: A Meta-Analysis of Randomized Controlled Trials. Adv. Nutr. 2023, 14, 270–282. [CrossRef]
- Zupo, R.; Castellana, F.; Lisco, G.; Corbo, F.; Crupi, P.; Sardone, R.; Panza, F.; Lozupone, M.; Rondanelli, M.; Clodoveo, M.L. Dietary Intake of Polyphenols and All-Cause Mortality: A Systematic Review with Meta-Analysis. Metabolites 2024, 14. [CrossRef]
- Potì, F.; Santi, D.; Spaggiari, G.; Zimetti, F.; Zanotti, I. Polyphenol Health Effects on Cardiovascular and Neurodegenerative Disorders: A Review and Meta-Analysis. Int. J. Mol. Sci. 2019, 20, 1–26. [CrossRef]
- Zubair, M.; Partyka, A.; Martyniuk, C.J. Polyphenols as a Strategy for Improving Male Reproductive System. Mol. Biol. Rep. 2025, 52, 132. [CrossRef]
- Biagi, M.; Noto, D.; Corsini, M.; Baini, G.; Cerretani, D.; Cappellucci, G.; Moretti, E. Antioxidant Effect of the Castanea Sativa Mill. Leaf Extract on Oxidative Stress Induced upon Human Spermatozoa. Oxid. Med. Cell. Longev. 2019, 2019:89260. [CrossRef]
- Cardoso, B.R.; Fratezzi, I.; Kellow, N.J. Nut Consumption and Fertility: A Systematic Review and Meta-Analysis. Adv. Nutr. 2024, 15, 100153. [CrossRef]
- Ferramosca, A.; Zara, V. Diet and Male Fertility: The Impact of Nutrients and Antioxidants on Sperm Energetic Metabolism. Int. J. Mol. Sci. 2022, 23. [CrossRef]
- Ranawat, P.; Pathak, C.M.; Khanduja, K.L. A New Perspective on the Quercetin Paradox in Male Reproductive Dysfunction. Phytother. Res. 2013, 27, 802–810. [CrossRef]
- Salas-Huetos, A.; Moraleda, R.; Giardina, S.; Anton, E.; Blanco, J.; Salas-Salvadó, J.; Bulló, M. Effect of Nut Consumption on Semen Quality and Functionality in Healthy Men Consuming a Western-Style Diet: A Randomized Controlled Trial. Am. J. Clin. Nutr. 2018, 108, 953–962. [CrossRef]
- Mataix, J. Tabla de Composición de Alimentos 4a Edición Corregida y Aumentada. Ed. 4aPublisher Editor. Univ. GranadaEditor Mataix JISBN 84-338-3050-3 2003.
- WHO World Health Organization WHO Laboratory Manual for the Examination and Processing of Human Semen FIFTH EDITION; 2024;
- Bucci, D.; Spinaci, M.; Mislei, B.; Gadani, B.; Rizzato, G.; Love, C.C.; Tamanini, C.; Galeati, G.; Mari, G. Epigallocatechin-3-Gallate (EGCG) and Green Tea Polyphenols Do Not Improve Stallion Semen Parameters during Cooling at 4°C. Reprod. Domest. Anim. 2017, 52, 270–277. [CrossRef]
- Akomolafe, S.F.; Oyeleye, S.I.; Oboh, G. Effect of Cashew (Anacardium Occidentale L.) Nut-Supplemented Diet on Steroidogenic Enzymes, Hormonal and Oxidative Imbalances, and Sperm Parameters in Cisplatin-Induced Reproductive Toxicity in Male Rats. J. Food Biochem. 2022, 46, e14100. [CrossRef]
- Vizzari, F.; Massányi, M.; Knížatová, N.; Corino, C.; Rossi, R.; Ondruška, Ľ.; Tirpák, F.; Halo, M.; Massányi, P. Effects of Dietary Plant Polyphenols and Seaweed Extract Mixture on Male-Rabbit Semen: Quality Traits and Antioxidant Markers. Saudi J. Biol. Sci. 2021, 28, 1017–1025. [CrossRef]
- Illiano, E.; Trama, F.; Zucchi, A.; Iannitti, R.G.; Fioretti, B.; Costantini, E. Resveratrol-Based Multivitamin Supplement Increases Sperm Concentration and Motility in Idiopathic Male Infertility: A Pilot Clinical Study. J. Clin. Med. 2020, 9. [CrossRef]
- Yuan, G.; Liu, Y.; Liu, G.; Wei, L.; Wen, Y.; Huang, S.; Guo, Y.; Zou, F.; Cheng, J. Associations between Semen Phytoestrogens Concentrations and Semen Quality in Chinese Men. Environ. Int. 2019, 129, 136–144. [CrossRef]
- Mongioì, L.M.; Perelli, S.; Condorelli, R.A.; Barbagallo, F.; Crafa, A.; Cannarella, R.; La Vignera, S.; Calogero, A.E. The Role of Resveratrol in Human Male Fertility. Molecules 2021, 26. [CrossRef]
- Cannarella, R.; Mehta, P.; Garofalo, V.; Kaiyal, R.S.; Kuroda, S.; Calogero, A.E.; Rajender, S. Resveratrol and Male Infertility: A Systematic Review of the Literature. Minerva Endocrinol. 2024. [CrossRef]
| Variables | n=106 |
|---|---|
| General characteristics | |
| Age (years) | 24.7 (4.7) |
| Weight (kg) | 75.0 (10.7) |
| BMI (kg/m2) | 23.8 (3.1) |
| Waist circumference (cm) | 81.4 (8.1) |
| Systolic blood pressure (mmHg) | 127.7 (11.6) |
| Diastolic blood pressure (mmHg) | 72.4 (8.1) |
| Dietary polyphenol intake | |
| Total polyphenols intake (mg/ day) | 404.7 [296.0 - 529.2] |
| Flavonoids (mg/day) | 244.6 [149.2 – 356.0] |
| Phenolic Acids (mg/day) | 93.0 [69.1 - 140.4] |
| Stilbenes (mg/day) | 0.02 [0.0 - 0.2] |
| Lignans (mg/day) | 0.3 [ 0.2 - 0.6] |
| Other Polyphenols (mg/ day) | 47.0 [25.0 - 75.5] |
| Biochemical variables | |
| Fasting plasma glucose (mg/dL) | 86 [82.3 - 92.8] |
| Total cholesterol (mg/dL) | 168 [150.0 - 187.8] |
| HDL-c (mg/dL) | 56 [50.0 - 64.8] |
| LDL-c (mg/dL) | 95 [77.0 – 106.0] |
| VLDL-c (mg/dL) | 13 [11.0 – 18.0] |
| Triglycerides (mg/dL) | 66 [55.3 - 89.5] |
| Fasting plasma insulin (mcUI/mL) | 5.5 [2.9 - 7.7] |
| C-reactive protein (mg/dL) | 0.2 [0.2 - 0.2] |
| Sperm parameters | |
| pH | 8 [8.0 - 8.5] |
| Volume (ml) | 3 [2.0 - 4.5] |
| Total sperm (x106) | 72.1 [27.2 – 122.5] |
| Sperm concentration (x106/mL) | 24.1 [10.9 – 42.0] |
| Vitality (%) | 79.3 [72.70 - 84.7] |
| Total motility (%) | 66.5 [48.2 - 74.8] |
| Progressive motility (%) | 47.3 [29.2 - 57.5] |
| Non-progressive motility (%) | 11.8 [8.2 - 15.5] |
| Immotility (%) | 33.6 [25.2 - 50.9] |
| Normal form (%) | 6.4 [5.2 - 7.9] |
| Abnormality in the sperm head (%) | 53.8 [42.3 - 66.3] |
| Abnormality in the mid-piece (%) | 11.4 [8.1 – 15.0] |
| Abnormality in the principal piece (%) | 12.7 [5.0 -29.1] |
| Combined abnormality (%) | 8.2 [6.5 - 13.39] |
| Nutrients intake | |
| Total energy intake (kcal/d) | 2,495.1 (613.6) |
| Carbohydrate intake (% E) | 43.6 (6.5) |
| Protein intake (% E) | 17.2 (3.4) |
| Fat intake (% E) | 36.9 (6.2) |
| Monounsaturated fatty acids (% FE) | 39.6 (6.8) |
| Polyunsaturated fatty acids (% FE) | 12.2 (4.0) |
| Saturated fatty acids (% FE) | 31.5 (6.2) |
| Dietary fibre intake (g/d) | 21.5 (9.4) |
| Alcohol intake (g/d) | 9.5 (15.1) |
| Sperm parameters | Total polyphenols intake | |||||
|---|---|---|---|---|---|---|
|
Tertile 1 (n=35) |
Tertile 2 (n=35) |
Tertile 3 (n= 36) |
P-trend |
β coefficient (95% CI) |
P-value | |
| Total polyphenols intake (mg/day) | 260.82 [186.61 - 292.48] | 404.75 [356.19 - 449.33] | 671.75 [535.86 - 783.21] | |||
| pH | Ref. | -0.001 (-0.009, 0.006) | 0.003 (-0.005, 0.012) | 0.37 | 0.005 (-0.010, 0.022) | 0.50 |
| Volume (mL) | Ref. | -0.024 (-0.170, 0.122) | -0.065 (-0.224, 0.094) | 0.41 | -0.075 (-0.377, 0.226) | 0.62 |
| Total sperm (x106) | Ref. | 0.077 (-0.199, 0.354) | 0.049 (-0.252, 0.351) | 0.41 | 0.310 (-0.257, 0.877) | 0.28 |
| Sperm concentration (x106/mL) | Ref. | 0.074 (-0.187, 0.336) | 0.060 (-0.224, 0.345) | 0.72 | 0.326 (-0.209, 0.863) | 0.23 |
| Vitality (%) | Ref. | 0.035 (-0.013, 0.084) | 0.025 (-0.027, 0.079) | 0.42 | 0.043 (-0.057, 0.145) | 0.40 |
| Total motility (%) | Ref. | 0.114 (-0.030, 0.258) | -0.040 (-0.197, 0.117) | 0.45 | 0.002 (-0.302, 0.308) | 0.99 |
| Progressive motility (%) | Ref. | 0.791 (-0.065, 1.647) | 0.224 (-0.707, 1.156) | 0.82 | 0.987 (-0.797, 2.772) | 0.28 |
| Non-progressive motility (%) | Ref. | -0.154 (-0.718, 0.408) | 0.007 (-0.606, 0.620) | 0.92 | 0.059 (-1.102, 1.221) | 0.92 |
| Immotility (%) | Ref. | -0.007 (-0.121 0.106) | 0.075 (-0.047, 0.199) | 0.19 | 0.069 (-0.166, 0.305) | 0.56 |
| Normal form (%) | Ref. | 0.001 (-0.086, 0.088) | 0.075 (-0.019, 0.171) | 0.09 | 0.125 (-0.056, 0.306) | 0.18 |
| Abnormality in the head (%) | Ref. | -0.047 (-0.111, 0.016) | -0.084 (-0.153, -0.014) | 0.02 * | -0.159 (-0.290, -0.027) | 0.02 * |
| Abnormality in the mid-piece (%) | Ref. | 0.024 (-0.090, 0.140) | 0.054 (-0.070, 0.179) | 0.39 | 0.032 (-0.205, 0.270) | 0.788 |
| Abnormality in the principal piece (%) | Ref. | 0.147 (-0.084, 0.379) | 0.375 (0.123, 0.627) | 0.004 ** | 0.651 (0.170, 1.132) | 0.01 ** |
| Combined abnormality (%) | Ref. | -0.190 (-0.334, -0.047) | -0.088 (-0.244, 0.067) | 0.44 | -0.136 (-0.441, 0.168) | 0.38 |
| Sperm parameters | Lignans | |||||
| Tertiles |
Tertile 1 (n=37) |
Tertile 2 (n=34) |
Tertile 3 (n=35) |
P-trend |
β coefficient (95% CI) |
P-value |
| Lignans intake (mg/day) | 0.11 [0.09 - 0.16] | 0.31 [0.23 - 0.40] | 0.84 [0.61 - 1.12] | |||
| pH | Ref | -0.001 (-0.008, 0.007) | 0.003 (-0.005, 0.012) | 0.36 | 0.001 (-0.005, 0.006) | 0.80 |
| Volume (ml) | Ref | -0.100 (-0.247 0.046) | -0.158 (-0.319, 0.003) | 0.08 | -0.056 (-0.161, 0.048) | 0.29 |
| Total sperm (x106) | Ref | -0.123 (-0.406 0.159) | -0.082 (-0.392, 0.227) | 0.77 | -0.073 (-0.272, 0.125) | 0.47 |
| Sperm concentration (x106/mL) | Ref | 0.038 (-0.228, 0.306) | 0.111 (-0.182, 0.405) | 0.44 | 0.004 (-0.183, 0.193) | 0.96 |
| Vitality (%) | Ref | 0.017 (-0.033, 0.067) | 0.010 (-0.044, 0.065) | 0.44 | -0.005 (-0.040, 0.030) | 0.77 |
| Total motility (%) | Ref | 0.085 (-0.064, 0.236) | 0.060 (-0.105, 0.225) | 0.68 | 0.025 (-0.081, 0.132) | 0.63 |
| Progressive motility (%) | Ref | 0.443 (-0.444, 1.330) | 0.298 (-0.676, 1.272) | 0.74 | 0.269 (-0.355, 0.894) | 0.40 |
| Non-progressive motility (%) | Ref | 0.393 (-0.176, 0.963) | 0.413 (-0.211, 1.039) | 0.31 | 0.129 (-0.275, 0.534) | 0.53 |
| Immotility (%) | Ref | 0.010 (-0.106, 0.128) | -0.019 (-0.148, 0.109) | 0.68 | 0.003 (-0.078, 0.086) | 0.93 |
| Normal form (%) | Ref | 0.058 (-0.031, 0.149) | 0.025 (-0.073, 0.124) | 0.91 | -0.008 (-0.072, 0.056) | 0.80 |
| Abnormality in the head (%) | Ref | -0.030 (-0.096,0.035) | -0.075 (-0.147, -0.003) | 0.04 * | -0.042 (-0.088, 0.004) | 0.08 |
| Abnormality in the mid-piece (%) | Ref | -0.054 (-0.172, 0.062) | -0.019 (-0.148, 0.109) | 0.10 | -0.063 (-0.145, 0.018) | 0.13 |
| Abnormality in the principal piece (%) | Ref | 0.116 (-0.125, 0.359) | 0.277 (0.011, 0.543) | 0.04 * | 0.162 (-0.008, 0.333) | 0.06 |
| Combined abnormality (%) | Ref | 0.008 (-0.141, 0.159) | 0.107 (-0.057, 0.272) | 0.15 | 0.056 (-0.050, 0.162) | 0.30 |
| Sperm parameters | Stilbenes | |||||
|
Tertile 1 (n=36) |
Tertile 2 (n= 36) |
Tertile 3 (n=34) |
P-trend |
β coefficient (95% CI) |
P-value | |
| Stilbenes intake (mg/day) | 0 [0 – 0.00001] | 0.02 [0 - 0.04] | 0.95 [0.22 - 2.56] | |||
| pH | Ref | -0.005 (-0.013, 0.001) | 0 (-0.009, 0.008) | 0.43 | -0.001 (-0.001, 0) | 0.18 |
| Volume (ml) | Ref | 0.189 (0.058, 0.321) | -0.004 (-0.156, 0.147) | 0.12 | 0.007 (-0.007, 0.022) | 0.30 |
| Total sperm (x106) | Ref | 0.184 (-0.071, 0.440) | -0.100 (-0.397, 0.195) | 0.12 | 0.003 (-0.024, 0.032) | 0.79 |
| Sperm concentration (x106/mL) | Ref | -0.022 (-0.270, 0.225) | -0.092 (-0.378, 0.194) | 0.52 | -0.004 (-0.031, 0.022) | 0.74 |
| Vitality (%) | Ref | -0.022 (-0.270, 0.225) | -0.092 (-0.378, 0.194) | 0.13 | -0.002 (-0.007, 0.002) | 0.36 |
| Total motility (%) | Ref | -0.036 (-0.175, 0.102) | -0.108 (-0.269, 0.052) | 0.21 | -0.007 (-0.022, 0.007) | 0.31 |
| Progressive motility (%) | Ref | -0.537 (-1.351, 0.276) | -0.717 (-1.659, 0.223) | 0.32 | -0.072 (-0.159, 0.014) | 0.10 |
| Non-progressive motility (%) | Ref | -0.311 (-0.833, 0.209) | 0.283 (-0.319, 0.886) | 0.08 | -0.003 (-0.060, 0.054) | 0.91 |
| Immotility (%) | Ref | -0.015(-0.123, 0.093) | 0.045 (-0.079, 0.170) | 0.32 | 0.002 (-0.009, 0.013) | 0.72 |
| Normal form (%) | Ref | -0.044 (-0.128, 0.039) | -0.053 (-0.150, 0.042) | 0.50 | -0.006 (-0.015, 0.002) | 0.17 |
| Abnormality in the head (%) | Ref | -0.008 -0.070, 0.053) | -0.038 (-0.109, 0.033) | 0.28 | -0.003 (-0.010, 0.003) | 0.31 |
| Abnormality in the mid-piece (%) | Ref | 0.004 (-0.103, 0.112) | 0.086 (-0.037, 0.211) | 0.12 | 0.004 (-0.010, 0.003) | 0.50 |
| Abnormality in the principal piece (%) | Ref | -0.019 (-0.248, 0.208) | 0.102 (-0.161, 0.366) | 0.32 | 0.008 (-0.010, 0.003) | 0.50 |
| Combined abnormality (%) | Ref | -0.010 (-0.146, 0.124) | 0.175 (0.018, 0.332) | 0.01 ** | 0.011 (-0.003, 0.026) | 0.14 |
| Sperm parameters | Flavonoids | |||||
|
Tertile 1 (n=35) |
Tertile 2 (n=35) |
Tertile 3 (n=36) |
P-trend |
β coefficient (95% CI) |
P-value | |
| Flavonoids intake (mg/day) | 124.56 [86.94 - 147.83] | 244.10 [213.67 - 283.93] | 412.56 [355.98 - 570.56] | |||
| pH | Ref | -0.001 (-0.008, 0.007) | 0.003 (-0.005, 0.011) | 0.37 | 0.002 (-0.008, 0.013) | 0.69 |
| Volume (ml) | Ref | 0.018 (-0.122, 0.158) | -0.003 (-0.145, 0.150) | 0.10 | -0.079 (-0.277, 0.117) | 0.42 |
| Total sperm (x106) | Ref | 0.201 (-0.059, 0.463) | 0.160 (-0.115, 0.436) | 0.32 | 0.189 (-0.182, 0.561) | 0.32 |
| Sperm concentration (x106) | Ref | 0.087 (-0.161, 0.337) | 0.084 (-0.179, 0.347) | 0.56 | 0.211 (-0.140, 0.562) | 0.24 |
| Vitality (%) | Ref | 0.023 (-0.023, 0.070) | 0.008 (-0.040, 0.058) | 0.82 | 0.003 (-0.063, 0.070) | 0.92 |
| Total Motility (%) | Ref | 0.040 (-0.099, 0.181) | -0.044 (-0.192, 0.103) | 0.47 | -0.062 (-0.261, 0.137) | 0.54 |
| Progressive motility (%) | Ref | 0.619 (-0.204, 1.442) | 0.365 (-0.502, 1.233) | 0.50 | 0.516 (-0.655, 1.688) | 0.38 |
| Non-progressive motility (%) | Ref | -0.175 (-0.711, 0.361) | 0.058 (-0.506, 0.624) | 0.75 | 0 (-0.760, 0.761) | 0.10 |
| Immotility (%) | Ref | -0.001 (-0.109, 0.106) | 0.084 (-0.029, 0.198) | 0.11 | 0.082 (-0.071, 0.236) | 0.29 |
| Normal form (%) | Ref | 0.043 (-0.039, 0.126) | 0.088 (0.0, 0.175) | 0.049 * | 0.091 (-0.027, 0.210) | 0.13 |
| Abnormality in the head (%) | Ref | -0.025(-0.086, 0.034) | -0.078 (-0.142, -0.014) | 0.01 * | - 0.086 (-0.173, 0.001) | 0.05 |
| Abnormality in the mid-piece (%) | Ref | -0.031 (-0.139, 0.077) | 0.053 (-0.061, 0.168) | 0.28 | 0.007 (-0.147, 0.163) | 0.92 |
| Abnormality in the principal piece (%) | Ref | 0.098 (-0.124, 0.321) | 0.305 (0.069, 0.540) | 0.01 ** | 0.371 (0.053, 0.689) | 0.02 * |
| Combined abnormality (%) | Ref | -0.124 (-0.264, 0.014) | -0.085 (-0.232, 0.062) | 0.34 | -0.129 (-0.328, 0.069) | 0.20 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).